Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Aβo) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of Aβo at Acumen and throughout the field. We are now on the on cusp of realizing the therapeutic potential of Aβo targeted drugs.
View Top Employees from Acumen Pharmaceuticals, Inc.| Website | http://www.acumenpharm.com |
| Ticker | ABOS |
| Revenue | $9 million |
| Employees | 61 (38 on RocketReach) |
| Founded | 1996 |
| Address | 427 Park St, Charlottesville, Virginia 22902, US |
| Phone | (434) 297-1000 |
| Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
| Industry | Biotechnology, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare, Health Diagnostics, Health Care |
| Competitors | Circuit Therapeutics, OYAGEN INC., Pascal Biosciences Inc., TARIS Bio, Visterra Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Acumen Pharmaceuticals, Inc. employee's phone or email?
Acumen Pharmaceuticals, Inc. Questions
The Acumen Pharmaceuticals, Inc. annual revenue was $9 million in 2024.
Eric Siemers is the Chief Medical Officer of Acumen Pharmaceuticals, Inc..
38 people are employed at Acumen Pharmaceuticals, Inc..
Acumen Pharmaceuticals, Inc. is based in Charlottesville, Virginia.
The NAICS codes for Acumen Pharmaceuticals, Inc. are [5417, 541, 541711, 54, 54171].
The SIC codes for Acumen Pharmaceuticals, Inc. are [283, 28].
Top Acumen Pharmaceuticals, Inc. Employees
-
ViewGrant Krafft
Co-Founder and Scientific Advisor at Acumen Pharmaceuticals, Inc.
New York, United States34 -
45+
-
25
-
ViewMatt Zuga
Chief Financial Officer and Chief Business Officer at Acumen Pharmaceuticals, Inc.
New York, New York, United States5+5 -
23
-
31
-
View
Qahera Munaim
Senior Scientist, Drug Product Formulation at Acumen Pharmaceuticals, Inc.
Los Angeles, CA, US4 -
View
Todd Feaster
Clinical Research Scientist at Acumen Pharmaceuticals, Inc.
Kennett Square, PA, US2
Related Companies
